期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

多囊卵巢综合征患者的胰岛素抵抗机制和治疗方法 被引量：5

Insulin Resistance in Polycystic Ovary Syndrome Mechanism and Treatment Methods
暂未订购
导出
摘要 多囊卵巢综合征(PCOS)是一种代谢性疾病,多数PCOS患者存在胰岛素抵抗(IR)。IR是PCOS的病理生理学基础,其发生机制包括肥胖和PCOS本身,任何体质量的患者均存在IR。PCOS患者的IR发生涉及胰岛素调节葡萄糖代谢过程的多个器官和环节。卵巢局部也存在IR。改变生活方式、控制体质量和使用胰岛素增敏剂是PCOS患者IR的重要治疗措施。 Polycystic ovary syndrome is a metabolic disease（PCOS）.Most patients have insulin resistance（IR） in PCOS.Insulin resistance is the pathophysiological basis of PCOS.Its mechanisms including obesity and PCOS itself.Patients have insulin resistance in any body weight.PCOS involving IR in insulin regulation of glucose metabolism in multiple organs and links.Ovary have IR too.Lifestyle changes,weight control and the use of insulin sensitizer in patients with polycystic ovary syndrome are the important therapeutic measures of IR.
作者 莫培培
机构地区 广西河池市中医院妇产科
出处 《医学综述》 2010年第16期2486-2488,共3页 Medical Recapitulate
关键词 多囊卵巢综合征 胰岛素抵抗 机制 治疗 Polycystic ovarian syndrome Insulin resistance Mechanism Therapy
分类号 R71 [医药卫生—妇产科学]
  • 相关文献

参考文献20

  • 1陈蓉,林守清.多囊卵巢综合征的临床演变[J].中国实用妇科与产科杂志,2007,23(9):727-730. 被引量：10
  • 2Hirschberg AL.Polycystic ovary syndrome,obesity and reproductive implications[J].Womens Health(Lond Engl),2009,5(5):529-540.
  • 3吴效科.多囊卵巢综合征可能是原发性卵泡病[J].中国实用妇科与产科杂志,2007,23(9):660-663. 被引量：36
  • 4Katsiki N,Georgiadou E,Hatzitolios AI.The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome[J].Drugs,2009,69(11):1417-1431.
  • 5Morin-Papunen LC,Vauhkonen I,Koivenen RM,et al.Insulin sensitivity,insulin secretion,and metabolic and hormonal parameters in healhy women with polycystic ovarian syndrome[J].Hum Report,2000,15(6):1266-1274.
  • 6朱雅男,王勇,吴效科.多囊卵巢综合征胰岛素抵抗的分子机制[J].中国实用妇科与产科杂志,2005,21(8):501-503. 被引量：14
  • 7Ciampelli M,Fulghesu AM,Cucinelli F,et al.Heterogeneity in beta cell activity insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome[J].Hum Report,1997,12(9):1897-1901.
  • 8Jaquet D,Vidal H,Hankard R,et al.Impaired regulation of glucose transporter 4 gene expression in insulin resistance associated with in utero undernutrition[J].J Clin Endocrinol Metab,2001,86(7):3266-3271.
  • 9Remsberg KE,Talbott EO,Zborowski JV,et al.Evidence for competing effects of body mass,hyperinsulinemia,insulinresistance,and androgens on leptin levels among lean,overweight,and obese women with polycystic ovary syndrome[J].Fertil Steril,2002,78(3):479-486.
  • 10Rice S,Christoforidis N,Gadd C,et al.Impaired insulin-dependent glucose metabolism in granulose-lutein cells from anovulatory women with polycystic ovaries[J].Hum Repord,2005,20(2):373-381.

二级参考文献83

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量：3093
  • 2李昕,林金芳.肥胖型多囊卵巢综合征患者临床及内分泌代谢特征的研究[J].中华医学杂志,2005,85(46):3266-3271. 被引量：141
  • 3林金芳,李昕,朱铭伟.多囊卵巢综合征的分型探讨[J].中华妇产科杂志,2006,41(10):684-688. 被引量：74
  • 4Palomba S, Orio F Jr, Falbo A, el al. Prospective parallel randomized, double-blind, double-dummy controlhd clinical trial composring clomiphene citrate and metfonnin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome [J].Glin Endocrinol Metab,2005, 90(7) :4068 -4074.
  • 5Rouzi AA, Ardawi MS. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and domiphene citrate in women with clomiphene citrate-resistant polycystic ovary syedrome [J]. Fertil Steril,2006, 85(2) :428 - 435.
  • 6Renato P, Alessandro G. Insulin-sensitizing agents in polycyatic ovary syndrome [J]. Eur J Endocrinol, 2006,154(6) :763 - 775.
  • 7Costello MF, Eden JA. A systematic review of the reproductive system effects of mefformin in patients with polycystic ovary syndrome [J]. Fertil Steril, 2003, 79(1): 1- 13.
  • 8Ben-Haroush A, Yogev Y, Fisch B.Insulin resistance and metformin in polycystic ovary syndrome [J]. Eur J Obstet Gynecol Reprod Biol, 2004, 115(2) : 125 - 133.
  • 9Glueck C J,Goldenberg N, Pranikoff J, et al. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued meffonnin through pregnancy [J]. Hum Reprod, 2004,19(6) : 1323- 1330.
  • 10Rantio KT, Katrina MP, Laure CT, et al. Rosiglitazone treatment alleviates inflammation and improves liver function in over weight women with poyeystie ovary syndrome: a randomized placebo-controlled study [J]. Fertil Steril, 2007,87( 1 ) : 202 - 206.

共引文献511

同被引文献31

  • 1周新华,刘启瑞.肥胖对多囊卵巢综合征患者糖和脂代谢的影响[J].中国误诊学杂志,2004,4(12):1981-1983. 被引量：6
  • 2曹云霞,魏兆莲.肥胖与多囊卵巢综合征[J].中国实用妇科与产科杂志,2004,20(12):709-711. 被引量：16
  • 3冯淑英.PCOS胰岛素抵抗发生机制与无排卵[J].实用妇产科杂志,2005,21(9):517-519. 被引量：24
  • 4李爱群,吴寿岭,元小冬,翟文杰,于立群,陈昕丽,李秋云,袁宝军,纪民惠,史丽平.2型糖尿病患者血清高敏C反应蛋白水平与代谢综合征的相关性研究[J].中国糖尿病杂志,2006,14(1):32-34. 被引量：21
  • 5乐杰．妇产科学[M]．第6版．北京：人民卫生出版社,2005．262．
  • 6Ehrmann DA. Polycystic ovary syndrome [ J ]. N Engl J Med,2005,352(7) :1223.
  • 7Rotterdam ESHRE/ASRM -Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS) [ J]. Hum Reprod,2004,19( 1 ) :41.
  • 8The Rotterdarn ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic crite- ria and longterm health risks related to polycystic ovary syn- drom. Fertil Steril, 2004,81 ( 1 ) : 19-25.
  • 9Kelly CC, Lyall H, Petrie JR, et al. Low grade chronic in flammation in women with polyeystic ovarian syndrome. Clin Endocrinol Metah,2001,86(6) :2453-2455.
  • 10熊永崂.多囊卵巢综合征中慢性炎症的初步研究.广州:中山大学,2009.

引证文献5

二级引证文献53

医学综述
2010年 第16期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部